Answers are grounded in this paper and cite their sources.
Demonstrates favorable clinical response and safety with high-dose cefazolin in endocarditis and bacteremia, indicating its effectiveness against susceptible gram-positive infections.
Seven patients with bacterial endocarditis and two patients with bacteremia were treated with cefazolin, with excellent bacteriologic and good clinical response. Dosage of cefazolin was 4–12 g daily. Large doses of cefazolin (12 g/day) were tolerated well by these patients without evidence of hematotoxicity, hepatotoxicity, or nephrotoxicity. Cefazolin is an effective antimicrobial agent for treatment of serious infections caused by susceptible gram-positive organisms.
No takes yet. Share an insight, caveat, or question.
Reinarz et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: